A

AVAX Technologies Inc
OTC:AVXT

Watchlist Manager
AVAX Technologies Inc
OTC:AVXT
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: 6.9k USD

Operating Margin
AVAX Technologies Inc

-1 027.1%
Current
-794%
Average
-4.3%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-1 027.1%
=
Operating Profit
-7.5m
/
Revenue
732k

Operating Margin Across Competitors

No Stocks Found

AVAX Technologies Inc
Glance View

Market Cap
6.9k USD
Industry
Biotechnology

AVAX Technologies, Inc. is an immuno-oncology company, which engages in the provision of development and commercialization of vaccine therapies and technologies for the treatment of cancer. The company is headquartered in Philadelphia, Pennsylvania and currently employs 29 full-time employees. The firm is focused on developing and commercializing its Autologous Cell (AC) Vaccine Technology Platform for the treatment of cancer. The AC Vaccine is a platform technology, which allows a patient's immune system to recognize its own cancer cells as foreign through the process of haptenization, cell processing and regimen of administration. The firm has approximately two vaccines that have completed Phase II clinical trials, both designated with Orphan Drug Status. MVAX is a post-surgical autologous cell vaccine for melanoma, which was approved to enter a Phase III-REGISTRATION trial for the treatment of Stage IV melanoma patients with measurable metastasis. OVAX is the Company's post-surgical autologous cell vaccine for Stage III and IV ovarian cancer. The OVAX trial is a Phase I/II trial that has completed enrollment and is in the process of gathering follow-up data on all patients.

AVXT Intrinsic Value
Not Available
A
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-1 027.1%
=
Operating Profit
-7.5m
/
Revenue
732k
What is the Operating Margin of AVAX Technologies Inc?

Based on AVAX Technologies Inc's most recent financial statements, the company has Operating Margin of -1 027.1%.

Back to Top